Docetaxel-Induced Stevens-Johnson Syndrome in a Patient with Metastatic Prostate Adenocarcinoma
Docetaxel is a commonly used chemotherapeutic agent in a variety of cancer treatment regimens. We present a case of apparent docetaxel-induced Stevens-Johnson syndrome (SJS) in a patient recently treated for metastatic prostate cancer. This medication is not classically associated with the developme...
Saved in:
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Case Reports in Oncological Medicine |
Online Access: | http://dx.doi.org/10.1155/2019/7928752 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832562109649518592 |
---|---|
author | Osama Diab Dan Mcentire Thamer Kassim Ali Nayfeh Abdel Rahman Dajani Mitchell Kerfeld Jonathon Campbell Adbullah Alsuwaidan Mahmoud Abu Hazeem Maryam Gbadamosi-Akindele |
author_facet | Osama Diab Dan Mcentire Thamer Kassim Ali Nayfeh Abdel Rahman Dajani Mitchell Kerfeld Jonathon Campbell Adbullah Alsuwaidan Mahmoud Abu Hazeem Maryam Gbadamosi-Akindele |
author_sort | Osama Diab |
collection | DOAJ |
description | Docetaxel is a commonly used chemotherapeutic agent in a variety of cancer treatment regimens. We present a case of apparent docetaxel-induced Stevens-Johnson syndrome (SJS) in a patient recently treated for metastatic prostate cancer. This medication is not classically associated with the development of SJS but in our case, along with a number of other case reports, and a single phase II clinical trial, an association was recognized. We encourage clinicians who employ the use of this medication to be aware of this relationship. |
format | Article |
id | doaj-art-4c633b81c7f844afadd0dfb6df0d527c |
institution | Kabale University |
issn | 2090-6706 2090-6714 |
language | English |
publishDate | 2019-01-01 |
publisher | Wiley |
record_format | Article |
series | Case Reports in Oncological Medicine |
spelling | doaj-art-4c633b81c7f844afadd0dfb6df0d527c2025-02-03T01:23:22ZengWileyCase Reports in Oncological Medicine2090-67062090-67142019-01-01201910.1155/2019/79287527928752Docetaxel-Induced Stevens-Johnson Syndrome in a Patient with Metastatic Prostate AdenocarcinomaOsama Diab0Dan Mcentire1Thamer Kassim2Ali Nayfeh3Abdel Rahman Dajani4Mitchell Kerfeld5Jonathon Campbell6Adbullah Alsuwaidan7Mahmoud Abu Hazeem8Maryam Gbadamosi-Akindele9Department of Medicine, Creighton University, Omaha, NE, USADepartment of Medicine, University of Utah, Salt Lake City, UT, USADepartment of Medicine, Creighton University, Omaha, NE, USADepartment of Medicine, Creighton University, Omaha, NE, USADepartment of Medicine, Norwalk Hospital, Norwalk, CT, USADepartment of Pathology, Creighton University, Omaha, NE, USADepartment of Medicine, Creighton University, Omaha, NE, USADepartment of Anesthesia, Mayo Clinic, Rochester, MN, USADepartment of Medicine, Creighton University, Omaha, NE, USADepartment of Medicine, Creighton University, Omaha, NE, USADocetaxel is a commonly used chemotherapeutic agent in a variety of cancer treatment regimens. We present a case of apparent docetaxel-induced Stevens-Johnson syndrome (SJS) in a patient recently treated for metastatic prostate cancer. This medication is not classically associated with the development of SJS but in our case, along with a number of other case reports, and a single phase II clinical trial, an association was recognized. We encourage clinicians who employ the use of this medication to be aware of this relationship.http://dx.doi.org/10.1155/2019/7928752 |
spellingShingle | Osama Diab Dan Mcentire Thamer Kassim Ali Nayfeh Abdel Rahman Dajani Mitchell Kerfeld Jonathon Campbell Adbullah Alsuwaidan Mahmoud Abu Hazeem Maryam Gbadamosi-Akindele Docetaxel-Induced Stevens-Johnson Syndrome in a Patient with Metastatic Prostate Adenocarcinoma Case Reports in Oncological Medicine |
title | Docetaxel-Induced Stevens-Johnson Syndrome in a Patient with Metastatic Prostate Adenocarcinoma |
title_full | Docetaxel-Induced Stevens-Johnson Syndrome in a Patient with Metastatic Prostate Adenocarcinoma |
title_fullStr | Docetaxel-Induced Stevens-Johnson Syndrome in a Patient with Metastatic Prostate Adenocarcinoma |
title_full_unstemmed | Docetaxel-Induced Stevens-Johnson Syndrome in a Patient with Metastatic Prostate Adenocarcinoma |
title_short | Docetaxel-Induced Stevens-Johnson Syndrome in a Patient with Metastatic Prostate Adenocarcinoma |
title_sort | docetaxel induced stevens johnson syndrome in a patient with metastatic prostate adenocarcinoma |
url | http://dx.doi.org/10.1155/2019/7928752 |
work_keys_str_mv | AT osamadiab docetaxelinducedstevensjohnsonsyndromeinapatientwithmetastaticprostateadenocarcinoma AT danmcentire docetaxelinducedstevensjohnsonsyndromeinapatientwithmetastaticprostateadenocarcinoma AT thamerkassim docetaxelinducedstevensjohnsonsyndromeinapatientwithmetastaticprostateadenocarcinoma AT alinayfeh docetaxelinducedstevensjohnsonsyndromeinapatientwithmetastaticprostateadenocarcinoma AT abdelrahmandajani docetaxelinducedstevensjohnsonsyndromeinapatientwithmetastaticprostateadenocarcinoma AT mitchellkerfeld docetaxelinducedstevensjohnsonsyndromeinapatientwithmetastaticprostateadenocarcinoma AT jonathoncampbell docetaxelinducedstevensjohnsonsyndromeinapatientwithmetastaticprostateadenocarcinoma AT adbullahalsuwaidan docetaxelinducedstevensjohnsonsyndromeinapatientwithmetastaticprostateadenocarcinoma AT mahmoudabuhazeem docetaxelinducedstevensjohnsonsyndromeinapatientwithmetastaticprostateadenocarcinoma AT maryamgbadamosiakindele docetaxelinducedstevensjohnsonsyndromeinapatientwithmetastaticprostateadenocarcinoma |